跳至主要内容
临床试验/PER-049-00
PER-049-00已完成未知

OPEN, CONTROLLED EXTENSION STUDY IN CHRONIC ASTHMA TO COMPARE THE EFFECT OF MONTELUKAST WITH PLACEBO IN PATIENTS FROM 2 TO 5 YEARS OF AGE

MERCK SHARP & DOHME PERU S.R.L.,0 个研究点目标入组 0 人开始时间: 2000年8月15日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • The patient arrived satisfactorily until Visit 24 of Protocol 072-11.
  • The parent / legal guardian accepts the patient´s participation in the study as indicated by the signature of the parent / legal guardian on the consent form. The patient and the parent / guardian are willing to comply with the procedures and both the patient and the parent / guardian can make the scheduled clinical visits.

排除标准

  • The consent of the parent or guardian can not be obtained.
  • The patient is hospitalized.
  • The patient suffered a serious or adverse clinically important experience that is still present at Visit 24 of Protocol 072-11.
  • The patient experiences significant changes from the clinical point of view in his general medical condition since he enrolled in Protocol 072-11.

研究者

发起方
MERCK SHARP & DOHME PERU S.R.L.,

相似试验

OPEN, CONTROLLED EXTENSION STUDY IN CHRONIC ASTHMA... | 临床试验